|
HBP
|
Model 1
|
Model 2
|
Model 3
|
|---|
|
OR (95% Cl)
|
P value
|
OR (95% Cl)
|
P value
|
OR (95% Cl)
|
P value
|
|---|
|
SBP-SDa
|
4.40 (4.28–4.51)
|
< 0.0001
|
4.15 (4.04–4.27)
|
< 0.0001
|
5.70 (5.54–5.87)
|
< 0.0001
|
|
SBP-ARVa
|
3.31 (3.25–3.38)
|
< 0.0001
|
3.23 (3.16–3.29)
|
< 0.0001
|
4.10 (4.01–4.20)
|
< 0.0001
|
|
SBP-CVa
|
1.00 (1.00–1.00)
|
0.671
|
1.00 (1.00–1.00)
|
0.867
|
1.00 (1.00–1.00)
|
0.857
|
|
DBP-SDa
|
4.88 (4.71–5.06)
|
< 0.0001
|
4.95 (4.77–5.13)
|
< 0.0001
|
4.70 (4.50–4.90)
|
< 0.0001
|
|
DBP-ARVa
|
3.56 (3.47–3.66)
|
< 0.0001
|
3.64 (3.54–3.74)
|
< 0.0001
|
3.39 (3.28–3.50)
|
< 0.0001
|
|
DBP-CVa
|
1.00 (1.00–1.00)
|
0.623
|
1.00 (1.00–1.00)
|
0.892
|
1.00 (1.00–1.00)
|
0.876
|
- Model 1 was unadjusted. Model 2 was adjusted for age and BMI in 2018, and sex. Model 3 further included SES, region, mean SBP and DBP z-scores during 2012–2017, and BP measurement times, based on model 2
- HBP, high blood pressure; DBP, diastolic blood pressure; SBP, systolic blood pressure; SD, standard deviation; ARV, actual real variability; CV, coefficient of variation
- aBP variability parameters were calculated based on BP z-scores during 2012–2017
